Converted Paper & Paperboard Prods (No Contaners/Boxes)SIC 2670
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Kimberly Clark Corp filings on SEC EDGAR ↗
Kimberly-Clark reported a significant increase in net income for the nine months ended September 30, 2026, reaching $2.83 billion compared to $1.54 billion in the prior year, primarily driven by a $1.44 billion gain from discontinued operations. Net sales for the nine-month period remained relatively stable at $12.49 billion, while operating profit saw a modest increase to $1.90 billion.
Kimberly-Clark reported third quarter 2026 net sales of $4.1 billion, down 0.4%, with organic sales declining 1.3% due to social media disruptions in China and inventory movements in North America. Adjusted EPS from continuing operations rose 17.2% to $1.70, while the company highlighted the completion of its Kenvue transaction as a defining strategic milestone.
Term
Q3 2026
“The completion of our Kenvue transaction earlier this week marks a defining moment in the 154 year history of Kimberly-Clark. We embark on an exciting next chapter focused on delivering better care, in more hands, and enabling smarter health.”
Mike Hsu, Kimberly-Clark Chairman and CEO
“Our third quarter results reflect a dynamic operating environment and several discrete impacts. Our team continues to execute with agility, and the underlying momentum of our business remains strong.”
Kimberly-Clark reported preliminary third quarter 2026 financial results, including net sales of $4.13 billion and diluted EPS of $5.37. The company reaffirmed its full-year 2026 outlook, expecting adjusted operating profit to grow mid-single digits on a constant-currency basis despite social media disruptions in China.